deltatrials
Completed NA NCT00002074

Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome

Sponsor: Pfizer

Conditions HIV Infections Meningitis, Cryptococcal
Interventions Amphotericin B Fluconazole
Updated 6 times since 2017 Last updated: Jun 23, 2005

A NA clinical study on HIV Infections and Meningitis, Cryptococcal, this trial is completed. The trial is conducted by Pfizer and has accumulated 6 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: NIH AIDS Clinical Trials Information Service

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albany, United States, Ann Arbor, United States, Atlanta, United States, Augusta, United States, Baltimore, United States, Birmingham, United States, Boston, United States, Chicago, United States, Cincinnati, United States, Decatur, United States and 22 more location s